Cite
HARVARD Citation
Rojas, J. et al. (2019). Brain volume loss and no evidence of disease activity over 3 years in multiple sclerosis patients under interferon beta 1a subcutaneous treatment. Journal of clinical neuroscience. pp. 175-178. [Online].